Effectiveness of Medicinal Plant Extract against Pathogenic Bacteria in the Prevention and Treatment of Urinary Tract Infections

被引:0
作者
Al-Hilu, Suad Abdulhadi [1 ]
Al-Shujairi, Wisam Hamzah [2 ]
机构
[1] Univ Kufa, Fac Sci, Dept Biol, Najaf, Iraq
[2] Univ Babylon, Dept Clin Lab Sci, Coll Pharm, Hilla 51001, Iraq
关键词
Urinary Tract Infections; Uropathogenic Bacteria; Medicinal Plant; Antibacterial Activity; PREGNANT-WOMEN; ANTIBIOTICS; RESISTANCE; SUSCEPTIBILITY; COMMUNITY;
D O I
10.22207/JPAM.18.1.61
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A urinary tract infection (UTI) is an infectious disease that infects humans in the presence of microorganisms, often not treated with broad-spectrum antibiotics because they contribute to developing resistant microorganisms. Therefore, this study aimed to investigate the antibacterial efficacy of medicinal plants used to treat infection in the urinary tract. One hundred samples were collected from patients with UTIs, ranging in age from 10-60 years. Outpatients and inpatients with UTIs live in Al-Najaf Center and attend treatment at Al-Hakeem Hospital and Al-Sader Teaching Hospital. Ten microliters of urine samples were inoculated on selective media to isolate and identify pathogenic bacteria, presumptive identification was performed using the VITECK-2 system. Eight antibiotics were used for showed antibiotic susceptibility: cefixime (5 mu g), streptomycin (25 mu g), amoxicillin (30 mu g), erythromycin (10 mu g), ciprofloxacin (10 mu g), azithromycin (15 mu g), gentamicin (10 mu g), and nitrofurantoin (50 mu g). Two species of plants were used to determine antibacterial activity: Castanea crenata and Saussurea costus. Of 100 urine samples, 80 tested positive for bacteriuria. Escherichia coli was the most prevalent bacterium in the urine 50 (62.5%), followed by Klebsiella pneumonia 10 (12.5%), Proteus vulgaris seven (8.75%), Pseudomonas aeruginosa six (7.5), Staphylococcus aureus four (5%), and Streptococcus pyogenes three (3.75%). Some bacteria with Gram staining comprising E. coli, Klebsiella spp., Pseudomonas spp., and Proteus spp. are resistant to many antibiotics. C. crenata and S. costus inhibited the growth of pathogenic bacteria isolated from the urine samples. Testing and determining the antimicrobial activities of medicinal plants will help pharmaceutical companies develop modifiers or precursors for synthesizing new therapeutic alternative drugs to treat infectious diseases caused by pathogens.
引用
收藏
页码:711 / 721
页数:11
相关论文
共 45 条
  • [1] Abbey T.C., 2019, CLIN MICROBIOL NEWSL, V41, P203, DOI [DOI 10.1016/J.CLINMICNEWS.2019.11.002, 10.1016/j.clinmicnews.2019.11.002]
  • [2] In-vitro anti-bacterial activity of medicinal plants against Urinary Tract Infection (UTI) causing bacteria along with their synergistic effects with commercially available antibiotics
    Acharjee, Mrityunjoy
    Zerin, Nagma
    Ishma, Touhida
    Mahmud, Md. Rayhan
    [J]. NEW MICROBES AND NEW INFECTIONS, 2023, 51
  • [3] Andreu Antonia, 2005, Enferm Infecc Microbiol Clin, V23 Suppl 4, P15, DOI 10.1157/13091444
  • [4] Angoti G., 2016, Nov. Biomed, V4, P1
  • [5] Assefa Addisu, 2008, Ethiop Med J, V46, P227
  • [6] BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
  • [7] Deep insights into urinary tract infections and effective natural remedies
    Bazzaz, Bibi Sedigheh Fazly
    Fork, Sareh Darvishi
    Ahmadi, Reza
    Khameneh, Bahman
    [J]. AFRICAN JOURNAL OF UROLOGY, 2021, 27 (01)
  • [8] Bacterial Profile and ESBL Screening of Urinary Tract Infection Among Asymptomatic and Symptomatic Pregnant Women Attending Antenatal Care of Northeastern Ethiopia Region
    Belete, Melaku Ashagrie
    [J]. INFECTION AND DRUG RESISTANCE, 2020, 13 : 2579 - 2591
  • [9] A Systematic Review on Drug Resistant Urinary Tract Infection Among Pregnant Women in Developing Countries in Africa and Asia; 2005-2016
    Belete, Melaku Ashagrie
    Saravanan, Muthupandian
    [J]. INFECTION AND DRUG RESISTANCE, 2020, 13 : 1465 - 1477
  • [10] Chandrasekhar Dilip, 2018, Journal of Basic and Clinical Physiology and Pharmacology, V29, P671, DOI 10.1515/jbcpp-2018-0015